<DOC>
	<DOCNO>NCT03090360</DOCNO>
	<brief_summary>To evaluate growth healthy term infant feed experimental infant formula prebiotic , commercial control infant formula probiotic , without prebiotic human breast milk</brief_summary>
	<brief_title>Growth Infants Fed New Term Infant Formula</brief_title>
	<detailed_description>Multisite , double-blind , randomize , control clinical trial . The purpose study determine infant feed standard infant formula prebiotic weight gain line infant feed standard starter infant formula without prebiotic .</detailed_description>
	<criteria>1 . Written inform consent sign dated 2 . Infants whose parent ( ) /Legally Authorized Representative ( LAR ) reach legal age majority Belgium 3 . Infants whose parent ( ) /LAR willing able comply schedule visit , requirement study protocol . 4 . Infants whose parent ( ) /LAR able contact directly telephone throughout study . 5 . Infants whose parent ( ) /LAR work freezer . 6 . Healthy term , singleton infant birth . 7 . At enrollment visit , postnatal age ≤ 14 day ( date birth = day 0 ) . 8 . At enrollment , birth weight ≥ 2500g ≤ 4500g . 9 . For formulafed group , infant parent ( ) /LAR previously make decision formula feed infant time enrollment . 1 . Infants condition require infant feeding specify protocol . 2 . Infants receive complementary food liquid . 3 . Infants medical condition history could increase risk associate study participation interfere interpretation study result . 4 . Infants presently receive receive prior enrollment medication could interfere interpretation study result . 5 . Infants infant whose parent ( ) /LAR Investigator 's assessment expect comply protocol study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Days</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Healthy baby</keyword>
	<keyword>Infant formula</keyword>
	<keyword>Growth</keyword>
</DOC>